SARATOGA INVESTMENT CORP.
SARAnalytical Summary
SARATOGA INVESTMENT CORP. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.
25-Year Financial Trajectory
QuarterlyBullish Indicators
- No bullish signals detected.
Bearish Risks
- Debt to EquityDebt to Equity is concerning (bottom quartile)
Health Breakdown
Dividend History
Dividend / share · sourced from SEC filingsStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2027 May 31, 2026 10-Q ↗ | Q4 FY2026 Feb 28, 2026 10-K ↗ | Q3 FY2026 Nov 30, 2025 10-Q ↗ | Q2 FY2026 Aug 31, 2025 10-Q ↗ | Q1 FY2026 May 31, 2025 10-Q ↗ | Q4 FY2025 Feb 28, 2025 10-K ↗ | Q3 FY2025 Nov 30, 2024 10-Q ↗ | Q2 FY2025 Aug 31, 2024 10-Q ↗ | Q1 FY2025 May 31, 2024 10-Q ↗ | Q4 FY2024 Feb 29, 2024 10-K ↗ | Q3 FY2024 Nov 30, 2023 10-Q ↗ | Q2 FY2024 Aug 31, 2023 10-Q ↗ | Q1 FY2024 May 31, 2023 10-Q ↗ | Q4 FY2023 Feb 28, 2023 10-K ↗ | Q3 FY2023 Nov 30, 2022 10-Q ↗ | Q2 FY2023 Aug 31, 2022 10-Q ↗ | Q1 FY2023 May 31, 2022 10-Q ↗ | Q4 FY2022 Feb 28, 2022 10-K ↗ | Q3 FY2022 Nov 30, 2021 10-Q ↗ | Q2 FY2022 Aug 31, 2021 10-Q ↗ | Q1 FY2022 Feb 28, 2021 10-Q ↗ | Q4 FY2021 Feb 28, 2021 10-K ↗ | Q4 FY2020 Feb 29, 2020 10-K ↗ | Q2 FY2011 Aug 12, 2010 10-Q ↗ | Q4 FY2010 Aug 12, 2010 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) | N/M |
-157.1%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
15.6%
Good
↓
Good
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-13.4%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
89.6%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M | N/M |
49.2%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
-73.8%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
712.5%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
83.3%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
131.9%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-30.1%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
-88.7%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — | — | — | — | — | — |
| Net Income Growth YoY (%) | N/M |
-286.1%
Weak
↓
Weak
Declining
Year-over-year change in net income |
35.8%
Excellent
↓
Excellent
Declining
Year-over-year change in net income |
-0.2%
Weak
Weak
Year-over-year change in net income |
110.8%
Excellent
Excellent
Year-over-year change in net income |
N/M | N/M |
68.7%
Excellent
Excellent
Year-over-year change in net income |
N/M |
-72.4%
Weak
↓
Weak
Declining
Year-over-year change in net income |
N/M |
732.5%
Excellent
Excellent
Year-over-year change in net income |
85.7%
Excellent
Excellent
Year-over-year change in net income |
— | — | — | — | — | — | — | — | — | — | — | — |
| FCF Growth YoY (%) | N/M | — | — | — |
-44.8%
Weak
Weak
Year-over-year change in free cash flow |
— | — | — | N/M | — | — |
88.4%
Excellent
Excellent
Year-over-year change in free cash flow |
-41.2%
Weak
Weak
Year-over-year change in free cash flow |
— | N/M | — | — | — | — | — | — | — | — | — | — |
| EPS CAGR 3Y (%) | — | — |
13.2%
Good
Good
Compound annual EPS growth over 3 years |
119.0%
Excellent
Excellent
Compound annual EPS growth over 3 years |
— | — |
-4.3%
Weak
Weak
Compound annual EPS growth over 3 years |
11.0%
Good
Good
Compound annual EPS growth over 3 years |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2027 May 31, 2026 10-Q ↗ | Q4 FY2026 Feb 28, 2026 10-K ↗ | Q3 FY2026 Nov 30, 2025 10-Q ↗ | Q2 FY2026 Aug 31, 2025 10-Q ↗ | Q1 FY2026 May 31, 2025 10-Q ↗ | Q4 FY2025 Feb 28, 2025 10-K ↗ | Q3 FY2025 Nov 30, 2024 10-Q ↗ | Q2 FY2025 Aug 31, 2024 10-Q ↗ | Q1 FY2025 May 31, 2024 10-Q ↗ | Q4 FY2024 Feb 29, 2024 10-K ↗ | Q3 FY2024 Nov 30, 2023 10-Q ↗ | Q2 FY2024 Aug 31, 2023 10-Q ↗ | Q1 FY2024 May 31, 2023 10-Q ↗ | Q4 FY2023 Feb 28, 2023 10-K ↗ | Q3 FY2023 Nov 30, 2022 10-Q ↗ | Q2 FY2023 Aug 31, 2022 10-Q ↗ | Q1 FY2023 May 31, 2022 10-Q ↗ | Q4 FY2022 Feb 28, 2022 10-K ↗ | Q3 FY2022 Nov 30, 2021 10-Q ↗ | Q2 FY2022 Aug 31, 2021 10-Q ↗ | Q1 FY2022 Feb 28, 2021 10-Q ↗ | Q4 FY2021 Feb 28, 2021 10-K ↗ | Q4 FY2020 Feb 29, 2020 10-K ↗ | Q2 FY2011 Aug 12, 2010 10-Q ↗ | Q4 FY2010 Aug 12, 2010 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
3.76x
Excellent
↓
Excellent
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
35.37x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.72x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-1.45x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.32x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
29.43x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
7.89x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-3.89x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
-0.90x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
520.09x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.70x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-3.74x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-63.53x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
53.93x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — | — | — | — | — |
| Metric | Q1 FY2027 May 31, 2026 10-Q ↗ | Q4 FY2026 Feb 28, 2026 10-K ↗ | Q3 FY2026 Nov 30, 2025 10-Q ↗ | Q2 FY2026 Aug 31, 2025 10-Q ↗ | Q1 FY2026 May 31, 2025 10-Q ↗ | Q4 FY2025 Feb 28, 2025 10-K ↗ | Q3 FY2025 Nov 30, 2024 10-Q ↗ | Q2 FY2025 Aug 31, 2024 10-Q ↗ | Q1 FY2025 May 31, 2024 10-Q ↗ | Q4 FY2024 Feb 29, 2024 10-K ↗ | Q3 FY2024 Nov 30, 2023 10-Q ↗ | Q2 FY2024 Aug 31, 2023 10-Q ↗ | Q1 FY2024 May 31, 2023 10-Q ↗ | Q4 FY2023 Feb 28, 2023 10-K ↗ | Q3 FY2023 Nov 30, 2022 10-Q ↗ | Q2 FY2023 Aug 31, 2022 10-Q ↗ | Q1 FY2023 May 31, 2022 10-Q ↗ | Q4 FY2022 Feb 28, 2022 10-K ↗ | Q3 FY2022 Nov 30, 2021 10-Q ↗ | Q2 FY2022 Aug 31, 2021 10-Q ↗ | Q1 FY2022 Feb 28, 2021 10-Q ↗ | Q4 FY2021 Feb 28, 2021 10-K ↗ | Q4 FY2020 Feb 29, 2020 10-K ↗ | Q2 FY2011 Aug 12, 2010 10-Q ↗ | Q4 FY2010 Aug 12, 2010 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
-1.8%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-0.7%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.9%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.2%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.5%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-0.2%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.4%
Weak
→
Weak
Stable
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.6%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.8%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.4%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-1.1%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.2%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-0.1%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
5.5%
Caution
↑
Caution
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.8%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
0.3%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-0.4%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — | — | — | — | — | — |
| Metric | Q1 FY2027 May 31, 2026 10-Q ↗ | Q4 FY2026 Feb 28, 2026 10-K ↗ | Q3 FY2026 Nov 30, 2025 10-Q ↗ | Q2 FY2026 Aug 31, 2025 10-Q ↗ | Q1 FY2026 May 31, 2025 10-Q ↗ | Q4 FY2025 Feb 28, 2025 10-K ↗ | Q3 FY2025 Nov 30, 2024 10-Q ↗ | Q2 FY2025 Aug 31, 2024 10-Q ↗ | Q1 FY2025 May 31, 2024 10-Q ↗ | Q4 FY2024 Feb 29, 2024 10-K ↗ | Q3 FY2024 Nov 30, 2023 10-Q ↗ | Q2 FY2024 Aug 31, 2023 10-Q ↗ | Q1 FY2024 May 31, 2023 10-Q ↗ | Q4 FY2023 Feb 28, 2023 10-K ↗ | Q3 FY2023 Nov 30, 2022 10-Q ↗ | Q2 FY2023 Aug 31, 2022 10-Q ↗ | Q1 FY2023 May 31, 2022 10-Q ↗ | Q4 FY2022 Feb 28, 2022 10-K ↗ | Q3 FY2022 Nov 30, 2021 10-Q ↗ | Q2 FY2022 Aug 31, 2021 10-Q ↗ | Q1 FY2022 Feb 28, 2021 10-Q ↗ | Q4 FY2021 Feb 28, 2021 10-K ↗ | Q4 FY2020 Feb 29, 2020 10-K ↗ | Q2 FY2011 Aug 12, 2010 10-Q ↗ | Q4 FY2010 Aug 12, 2010 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) |
2.16x
Weak
↑
Weak
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.87x
Weak
→
Weak
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.87x
Weak
→
Weak
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.92x
Weak
↓
Weak
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
2.00x
Weak
Weak
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— |
2.24x
Weak
Weak
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — | — |
0.00x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— |
2.40x
Weak
Weak
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt (USD) | $771.23M | $737.69M | $722.08M | $680.71M | $659.81M | $-148.22M | $690.26M | $-84.57M | $-32.23M | $-8.69M | $-20.58M | — | $786.39M | $-65.75M | — | — | — | $-47.26M | — | $-60.27M | — | — | — | — | — |
| Metric | Q1 FY2027 May 31, 2026 10-Q ↗ | Q4 FY2026 Feb 28, 2026 10-K ↗ | Q3 FY2026 Nov 30, 2025 10-Q ↗ | Q2 FY2026 Aug 31, 2025 10-Q ↗ | Q1 FY2026 May 31, 2025 10-Q ↗ | Q4 FY2025 Feb 28, 2025 10-K ↗ | Q3 FY2025 Nov 30, 2024 10-Q ↗ | Q2 FY2025 Aug 31, 2024 10-Q ↗ | Q1 FY2025 May 31, 2024 10-Q ↗ | Q4 FY2024 Feb 29, 2024 10-K ↗ | Q3 FY2024 Nov 30, 2023 10-Q ↗ | Q2 FY2024 Aug 31, 2023 10-Q ↗ | Q1 FY2024 May 31, 2023 10-Q ↗ | Q4 FY2023 Feb 28, 2023 10-K ↗ | Q3 FY2023 Nov 30, 2022 10-Q ↗ | Q2 FY2023 Aug 31, 2022 10-Q ↗ | Q1 FY2023 May 31, 2022 10-Q ↗ | Q4 FY2022 Feb 28, 2022 10-K ↗ | Q3 FY2022 Nov 30, 2021 10-Q ↗ | Q2 FY2022 Aug 31, 2021 10-Q ↗ | Q1 FY2022 Feb 28, 2021 10-Q ↗ | Q4 FY2021 Feb 28, 2021 10-K ↗ | Q4 FY2020 Feb 29, 2020 10-K ↗ | Q2 FY2011 Aug 12, 2010 10-Q ↗ | Q4 FY2010 Aug 12, 2010 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LT Debt (USD) | $817.38M | $739.38M | $774.38M | $786.38M | $791.38M | — | $837.88M | — | — | — | $811.38K | — | $808.38M | — | — | — | — | — | — | — | — | — | — | — | — |
| Total Equity (USD) | $378.45M | $396.16M | $413.21M | $410.50M | $396.37M | $392.67M | $374.87M | $372.05M | $367.86M | $370.22M | $359.56M | $362.08M | $337.45M | $346.96M | $335.76M | $337.21M | $345.24M | $355.78M | $342.60M | $324.11M | $304.19M | $304.19M | — | — | — |
| Metric | Q1 FY2027 May 31, 2026 10-Q ↗ | Q4 FY2026 Feb 28, 2026 10-K ↗ | Q3 FY2026 Nov 30, 2025 10-Q ↗ | Q2 FY2026 Aug 31, 2025 10-Q ↗ | Q1 FY2026 May 31, 2025 10-Q ↗ | Q4 FY2025 Feb 28, 2025 10-K ↗ | Q3 FY2025 Nov 30, 2024 10-Q ↗ | Q2 FY2025 Aug 31, 2024 10-Q ↗ | Q1 FY2025 May 31, 2024 10-Q ↗ | Q4 FY2024 Feb 29, 2024 10-K ↗ | Q3 FY2024 Nov 30, 2023 10-Q ↗ | Q2 FY2024 Aug 31, 2023 10-Q ↗ | Q1 FY2024 May 31, 2023 10-Q ↗ | Q4 FY2023 Feb 28, 2023 10-K ↗ | Q3 FY2023 Nov 30, 2022 10-Q ↗ | Q2 FY2023 Aug 31, 2022 10-Q ↗ | Q1 FY2023 May 31, 2022 10-Q ↗ | Q4 FY2022 Feb 28, 2022 10-K ↗ | Q3 FY2022 Nov 30, 2021 10-Q ↗ | Q2 FY2022 Aug 31, 2021 10-Q ↗ | Q1 FY2022 Feb 28, 2021 10-Q ↗ | Q4 FY2021 Feb 28, 2021 10-K ↗ | Q4 FY2020 Feb 29, 2020 10-K ↗ | Q2 FY2011 Aug 12, 2010 10-Q ↗ | Q4 FY2010 Aug 12, 2010 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $-6.90M | $-2.61M | $12.00M | $13.29M | $13.93M | $-676.76K | $8.83M | $13.32M | $6.61M | $5.31M | $-4.06M | $7.90M | $-213.26K | $19.20M | $6.01M | $948.43K | $-1.49M | — | — | — | — | — | — | — | — |
| Operating Cash Flow (USD) | $-25.97M | $-92.42M | $-8.60M | $-19.30M | $32.29M | $-19.92M | — | — | $52.15M | $-20.66M | — | $-7.08M | $-110.91M | $32.56M | $-22.46M | $-60.26M | $-80.21M | $-146.20M | $15.29M | — | — | — | — | — | — |
Secondary lens
Benchmark Lens
Compare SAR against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare SAR against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for SAR
No bullish signals detected
Debt to Equity is concerning (bottom quartile)
Percentile Rankings
How SAR compares to all companies
Compare SAR with peers
Stack SAR against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 8 years · 25 quarters